0000891293-18-000056.txt : 20180517 0000891293-18-000056.hdr.sgml : 20180517 20180517162509 ACCESSION NUMBER: 0000891293-18-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180516 FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER JACK W CENTRAL INDEX KEY: 0001204264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28386 FILM NUMBER: 18843343 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-05-16 0 0000891293 CTI BIOPHARMA CORP ctic 0001204264 SINGER JACK W 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 0 1 0 0 EVP, Chief Scientific Officer Non-Qualified Stock Option (right to buy) 4.14 2018-05-16 4 A 0 94433 0 A 2028-05-16 Common Stock 94433 94433 D The stock options will vest in six equal semi-annual installments over a three-year period commencing on March 9, 2018 subject to continued employment with the Company through the applicable vesting dates, such that the option will be fully vested on March 9, 2021. Bruce J. Seeley, Attorney-in-fact For: Jack W. Singer 2018-05-17